RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)

CUSIP: 75629V104

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Class A Stock
Shares outstanding
525,302,736
Total 13F shares
251,836,128
Share change
+40,762,649
Total reported value
$1,888,574,788
Put/Call ratio
248%
Price per share
$7.50
Number of holders
264
Value change
+$298,622,706
Number of buys
174
Number of sells
94

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAILLIE GIFFORD & CO
13F
Company
mixed-class rows
257,067,477
mixed-class rows
$510,235,627 31 Mar 2024
13F
ARK Investment Management LLC
13F
Company
mixed-class rows
214,194,469
mixed-class rows
$465,081,992 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
mixed-class rows
141,871,428
mixed-class rows
$305,660,926 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
mixed-class rows
85,183,127
mixed-class rows
$207,360,747 31 Mar 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
mixed-class rows
66,227,851
mixed-class rows
$168,120,602 31 Mar 2024
13F
Amova Asset Management Americas, Inc.
13F
Company
mixed-class rows
66,227,851
mixed-class rows
$167,913,346 31 Mar 2024
13F
VIKING GLOBAL INVESTORS LP
13F
Company
37%
143,085,126
$165,978,746 31 Mar 2024
13F
Lux Ventures IV, L.P.
3/4/5
Former 10% Owner
class O/S missing
13,021,519
$137,710,376 07 Dec 2021
Mubadala Investment Co PJSC
3/4/5 13F
10%+ Owner · Company
2.5%
from 13F
12,985,927
$137,333,970 02 Mar 2023
STATE STREET CORP
13F
Company
mixed-class rows
36,937,850
mixed-class rows
$134,052,162 31 Mar 2024
13F
Kinnevik AB (publ)
13F
Company
2%
10,405,668
$103,744,510 31 Mar 2024
13F
FMR LLC
13F
Company
mixed-class rows
9,286,777
mixed-class rows
$92,360,939 31 Mar 2024
13F
MIC Capital Management UK LLP
13F
Company
1.6%
8,451,758
$84,264,027 31 Mar 2024
13F
Anchorage Capital Group, L.L.C.
13F
Company
18%
69,854,593
$81,031,328 31 Mar 2024
13F
NVIDIA CORP
13F
Company
1.5%
7,706,363
$76,832,439 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
mixed-class rows
51,035,038
mixed-class rows
$76,501,525 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
mixed-class rows
25,341,730
mixed-class rows
$59,811,350 31 Mar 2024
13F
Data Collective IV GP, LLC
13F
Company
1.1%
5,941,120
$59,232,966 31 Mar 2024
13F
NORGES BANK
13F
Company
mixed-class rows
18,653,532
mixed-class rows
$49,588,192 31 Mar 2024
13F
Zachary Bogue
3/4/5
Director, 10%+ Owner
class O/S missing
3,736,341
$39,514,048 03 Jul 2023
DCVC Opportunity Fund II GP, LLC
13F
Company
0.75%
3,951,141
$39,392,876 31 Mar 2024
13F
Lingotto Investment Management LLP
13F
Company
mixed-class rows
12,186,378
mixed-class rows
$33,298,627 31 Mar 2024
13F
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
6.4%
24,429,191
$28,337,862 31 Mar 2024
13F
GLENVIEW CAPITAL MANAGEMENT, LLC
13F
Company
6.3%
24,000,000
$27,840,000 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
mixed-class rows
9,105,584
mixed-class rows
$21,249,113 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.4%
2,095,000
$20,887,150 31 Mar 2024
13F
CREDIT SUISSE AG/
13F
Company
mixed-class rows
3,082,903
mixed-class rows
$20,640,873 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
mixed-class rows
4,820,146
mixed-class rows
$20,594,042 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
mixed-class rows
7,253,285
mixed-class rows
$19,749,550 31 Mar 2024
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.34%
1,800,469
$17,950,676 31 Mar 2024
13F
Legal & General Group Plc
13F
Company
mixed-class rows
11,589,547
mixed-class rows
$14,884,648 31 Mar 2024
13F
Vestmark Advisory Solutions, Inc.
13F
Company
mixed-class rows
5,968,566
mixed-class rows
$14,852,704 31 Mar 2024
13F
MIC Capital Partners (Public) Parallel Cayman, LP
3/4/5
10%+ Owner
class O/S missing
1,388,889
$14,688,335 01 Nov 2021
Bank of New York Mellon Corp
13F
Company
mixed-class rows
4,719,769
mixed-class rows
$13,243,675 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
mixed-class rows
5,111,975
mixed-class rows
$12,950,598 31 Mar 2024
13F
Erste Asset Management GmbH
13F
Company
mixed-class rows
10,833,500
mixed-class rows
$12,868,695 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
mixed-class rows
10,586,178
mixed-class rows
$12,377,555 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
mixed-class rows
1,684,255
mixed-class rows
$11,487,081 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
mixed-class rows
3,061,338
mixed-class rows
$11,453,898 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
mixed-class rows
3,407,561
mixed-class rows
$11,299,183 31 Mar 2024
13F
Liontrust Investment Partners LLP
13F
Company
mixed-class rows
3,650,000
mixed-class rows
$10,841,500 31 Mar 2024
13F
Comprehensive Financial Management LLC
13F
Company
mixed-class rows
1,648,197
mixed-class rows
$10,210,003 31 Mar 2024
13F
CITIGROUP INC
13F
Company
mixed-class rows
2,170,550
mixed-class rows
$9,576,296 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
mixed-class rows
1,293,861
mixed-class rows
$9,343,885 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
mixed-class rows
1,009,632
mixed-class rows
$9,069,162 31 Mar 2024
13F
Laurion Capital Management LP
13F
Company
0.17%
907,616
$9,048,932 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
mixed-class rows
4,869,432
mixed-class rows
$8,647,235 31 Mar 2024
13F
WELCH & FORBES LLC
13F
Company
1.8%
7,000,000
$8,120,000 31 Mar 2024
13F
UBS Group AG
13F
Company
mixed-class rows
1,283,028
mixed-class rows
$7,412,430 31 Mar 2024
13F
Mitsubishi UFJ Trust & Banking Corp
13F
Company
mixed-class rows
3,943,070
mixed-class rows
$6,955,833 31 Mar 2024
13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q2 2024

As of 30 Jun 2024, RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by 264 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 251,836,128 shares. The largest 10 holders included ARK Investment Management LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., Mubadala Investment Co PJSC, Kinnevik AB (publ), Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., and STATE STREET CORP. This page lists 265 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
242
Q2 2024 holders
264
Holder diff
22
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .